tesaglitazar has been researched along with Obesity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhti, M; Bastidas-Ponce, A; Baugé, E; Campbell, JE; Capozzi, M; Clemmensen, C; Collden, G; Cota, P; DiMarchi, RD; Douros, J; Drucker, DJ; DuBois, B; Feuchtinger, A; Finan, B; Garcia-Caceres, C; Grandl, G; Harger, A; Hennuyer, N; Herzig, S; Hofmann, SM; Klingelhuber, F; Knerr, PJ; Krahmer, N; Kulaj, K; Lalloyer, F; Lickert, H; Liskiewicz, A; Liskiewicz, D; Maity, G; Müller, TD; Novikoff, A; Perez-Tilve, D; Prakash, S; Quarta, C; Sanchez-Garrido, MA; Staels, B; Stemmer, K; Tschöp, MH; Yang, B; Zhang, Q | 1 |
| Aguilar, E; Asghar, A; Ebenezer, P; Ferder, L; Francis, J; Hu, X; Isidro-Carrión, AA; Liao, J; Reisin, E; Soltani, Z; Zhang, R | 1 |
| Bamberg, K; Camejo, G; Dahllöf, B; Kjellstedt, A; Ljung, B; Oakes, ND; Ostling, J; Svensson, L | 1 |
| Camejo, G; Hultstrand, T; Jacinto, S; Ljung, B; Oakes, ND; Thalén, P; Wallin, B | 1 |
4 other study(ies) available for tesaglitazar and Obesity
| Article | Year |
|---|---|
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
Topics: Alkanesulfonates; Animals; Body Weight; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Male; Mice; Obesity; Phenylpropionates; PPAR alpha | 2022 |
Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.
Topics: Alkanesulfonates; Animals; Blood Pressure; Glomerular Filtration Rate; Kidney; Kidney Diseases; Metabolic Syndrome; Obesity; Phenylpropionates; PPAR alpha; PPAR gamma; Rats; Rats, Zucker | 2010 |
AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.
Topics: Alkanesulfonates; Animals; Bezafibrate; Carbohydrate Metabolism; Cinnamates; Diabetes Mellitus; Fatty Acids; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Male; Mass Spectrometry; Mice; Mice, Obese; Molecular Structure; Obesity; Phenylpropionates; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tumor Cells, Cultured | 2002 |
Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
Topics: Administration, Oral; Alkanesulfonates; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucose; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Metabolic Syndrome; Obesity; Phenylpropionates; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; Treatment Outcome; Triglycerides | 2005 |